Related by context. All words. (Click for frequent words.) 76 antiretroviral naïve 73 relapsed MM 72 PREZISTA r 72 APTIVUS r 72 virologic failure 71 TDF FTC 71 virologically suppressed 70 recurrent glioblastoma multiforme 70 ritonavir boosted 69 treatment naive genotype 69 atazanavir ritonavir 69 abacavir lamivudine 69 BARACLUDE ® 68 β blockers 68 treatment naïve genotype 68 ribavirin RBV 68 insulin detemir 68 AZT zidovudine Retrovir 68 venlafaxine XR 68 8mg/kg 68 tipranavir r 68 tenofovir emtricitabine 68 naïve HCV 68 LEXIVA r 68 HCV infected 67 HBeAg positive 67 AGILECT R 67 PREZISTA ritonavir 67 severe neutropenia 67 4mg/kg 67 dose escalation phase 67 genotypic resistance 67 octreotide LAR 67 pharmacokinetic interactions 67 enfuvirtide 67 HCV RESPOND 2 67 APTIVUS ritonavir 67 HIV seronegative 67 HIV HCV coinfected 67 desvenlafaxine succinate 67 maximal doses 67 KRAS mutant tumors 67 alfa 2a 67 null responder 67 weekly subcutaneous injections 67 heavily pretreated 67 candidemia 67 tolterodine 67 moderate hepatic impairment 66 mild renal insufficiency 66 ribavirin therapy 66 tipranavir ritonavir 66 virological response 66 R entecavir 66 R# #mg BID 66 REYATAZ r arm 66 β blocker 66 mitoxantrone plus 66 nelfinavir 66 IFN beta 66 patients coinfected 66 Teriflunomide 66 reduce serum phosphate 66 SCIg 66 adalimumab Humira 66 protease inhibitor PI 66 APTIVUS 66 mGluR5 NAM 66 prospectively stratified 66 3TC lamivudine Epivir 66 HIV coinfected 66 interferon ribavirin 66 opioid naive 66 dose proportionality 66 discontinued Viread 66 insulin glulisine 66 receiving VELCADE 66 INVEGA ® 66 evaluating tivozanib 66 fluvastatin 66 darunavir ritonavir 66 Hepsera adefovir dipivoxil 66 HBeAg negative 66 mg RDEA# 66 estramustine 66 Aptivus ® 66 eosinophilic asthma 66 achieved CCyR 66 hyperphenylalaninemia HPA due 66 indinavir 66 achieved ACR# 66 Naive Patients 65 q#h 65 NATRECOR R 65 q8h 65 Newly Diagnosed Multiple Myeloma 65 RRMS patients 65 de novo kidney transplant 65 paricalcitol 65 progressive PsA 65 canakinumab 65 PREZISTA rtv 65 elevated ALT 65 demonstrated antitumor activity 65 mg q#h 65 nicardipine 65 HIV RNA 65 mg/m2 dose 65 nucleoside naive 65 refractory NSCLC 65 receiving immunosuppressive therapy 65 dalteparin 65 anagrelide 65 #mg ATC 65 nitazoxanide 65 TMP SMX 65 seroconverted 65 intradermal injections 65 CCR5 tropic HIV 65 deep venous thromboses 65 daily subcutaneous injections 65 ZOLINZA 65 evaluable subjects 65 bortezomib refractory 65 thrombocytopenic 65 selective modulator 65 peginterferon 65 K ras mutations 65 administered subcutaneously 65 plus OBT 65 peginterferon alfa 65 HBeAg seroconversion 65 PegIFN RBV 65 sustained virologic response 65 mcg BID 65 ß blockers 65 NNRTI resistant virus 65 viral kinetics 65 #mg/day [001] 65 intravenous bolus 65 RSD# oral 65 efalizumab 65 cART 65 hepatitis C genotype 65 serum phosphate 65 flutamide 65 rimonabant #mg 65 Immune reconstitution syndrome 65 weekly intravenous infusions 65 bone marrow reticulin deposition 65 HIV uninfected 65 BEXXAR Therapeutic Regimen 65 NATRECOR ® 65 urocortin 2 65 #mg/day [002] 65 FFNS 65 ACTEMRA TM 65 riociguat 65 HBeAg positive patients 65 lenalidomide Revlimid R 65 plus methotrexate 65 plus prednisone prednisolone 65 EXJADE 65 galiximab 65 NNRTI resistance 65 receiving XGEVA 65 #mg QD [001] 64 nonnucleoside reverse transcriptase inhibitors 64 pegylated interferon alpha 64 LATUDA 64 Relapsing Multiple Sclerosis 64 vicriviroc 64 refractory CLL 64 BENICAR HCT 64 ritonavir boosted protease inhibitor 64 oral FTY# 64 metastatic RCC 64 salmeterol fluticasone 64 antiandrogen 64 highly emetogenic 64 recurrent genital herpes 64 divalproex sodium 64 FUSILEV enhances 64 AML MDS 64 #mg QD [002] 64 MAGE A3 ASCI 64 rituximab refractory 64 MERLIN TIMI 64 #mg BID [001] 64 Forodesine HCl 64 receiving prophylactic anticoagulation 64 lenalidomide dexamethasone 64 HAART regimen 64 ARCALYST ® 64 subcutaneously administered 64 azilsartan medoxomil 64 dexmedetomidine 64 relapsed ALL 64 dosing cohorts 64 nadolol 64 virological failure 64 protease inhibitors PIs 64 mg Pycnogenol 64 GnRH agonist 64 serum phosphorous 64 CIMZIA TM certolizumab pegol 64 HCV SPRINT 64 fosamprenavir 64 Cariprazine 64 undetectable viral 64 HBeAg + 64 OADs 64 pomalidomide 64 CIMZIA TM 64 Hepatotoxicity 64 achieved sustained virologic 64 dopamine partial agonist 64 nevirapine Viramune 64 uric acid lowering 64 receiving INTRON 64 pyridostigmine 64 CIMZIA R 64 null responder HCV 64 alfuzosin 64 LEVAQUIN ® 64 plasma pharmacokinetics 64 coinfected patients 64 suboptimal adherence 64 venlafaxine ER 64 NPH insulin 64 imatinib therapy 64 underwent liver transplantation 64 clomipramine 64 stable angina 64 corrected QT interval 64 oral rivaroxaban 64 ritonavir boosted atazanavir 64 HCV genotype 1 64 avosentan 64 chronic HCV infection 64 rilpivirine 64 undetectable HBV DNA 64 normotensive 64 elevated transaminases 64 TMC# r 64 pyrazinamide 64 somatostatin analog 64 Intravenous immunoglobulin 64 paclitaxel cisplatin 64 posaconazole 64 INTELENCE 64 Elotuzumab 64 stavudine d4T 64 severe hypersensitivity reactions 64 Raptiva r 64 dapagliflozin plus 64 virologic response 64 CANCIDAS 64 pentoxifylline 64 pegylated liposomal doxorubicin 64 HMG CoA reductase inhibitors 64 coinfected 64 RLAI 64 amisulpride 64 pegylated alpha interferon 64 ritonavir boosted lopinavir 64 CD4 + cell 64 Viread Emtriva 64 mcg QD 64 aplindore 64 HBeAg negative patients 64 lamivudine refractory patients 64 cMET 64 Traficet EN 64 Pegasys plus Copegus 64 decompensated liver disease 63 invasive aspergillosis 63 postintervention 63 progression TTP 63 clevidipine 63 BARACLUDE R 63 receiving TNF blockers 63 chronic HBV 63 virologic breakthrough 63 Myelodysplastic Syndrome MDS 63 TMC# C# 63 undetectable viral loads 63 KRAS mutations occur 63 Relapsed Multiple Myeloma 63 randomized #:#:# 63 amoxicillin clavulanate 63 Flu Cy 63 double blinded placebo 63 voriconazole 63 mg kg dose 63 #mg/m# [001] 63 anthracyclines taxanes 63 STELARA ® 63 Chronic Hepatitis C 63 recurrent VTE 63 interferon alfa 2b 63 pegylated interferon peg IFN 63 del 5q MDS 63 stage IIIb IV 63 methotrexate monotherapy 63 dosage regimens 63 IFN α 63 REYATAZ ® 63 HCV genotype 63 aged ≥ 63 blastic phase 63 low dose cytarabine 63 containing abacavir 63 mcg kg REBETOL 63 HeFH 63 Mg Uk 63 corticosteroid dose 63 sitaxsentan 63 T2DM 63 IMiDs ® compound 63 Heterozygous Familial Hypercholesterolemia 63 detectable HCV RNA 63 Known hypersensitivity 63 neutropenic patients 63 ISENTRESS 63 omega interferon 63 solifenacin 63 ancrod 63 trastuzumab Herceptin ® 63 maximally tolerated dose 63 anthracycline taxane 63 adefovir 63 darunavir r 63 achieve sustained virologic 63 T1DM 63 Juvenile Idiopathic Arthritis 63 perioperatively 63 adult chronic ITP 63 certolizumab 63 ascending dose 63 achieved sustained virological 63 postmenopausal osteoporotic women 63 alefacept 63 Vacc 4x 63 im peramivir 63 % CI #.#-#.# [003] 63 elotuzumab 63 lopinavir r 63 aflibercept VEGF Trap 63 peak plasma concentrations 63 baseline HbA1c 63 CML CP 63 SPRYCEL ® 63 coadministration 63 experienced virologic failure 63 CYT# potent vascular disrupting 63 hepatorenal syndrome 63 NOXAFIL Oral Suspension 63 Peginterferon 63 combination antiretroviral therapy 63 VELCADE melphalan 63 forodesine 63 Infusion Reactions Severe 63 mg eq 63 nadroparin 63 #I TM# 63 Sprycel dasatinib 63 relapsing remitting MS RRMS 63 intravenous iv 63 nucleoside analog 63 PROSTVAC VF 63 seroprotection 63 CR nPR 63 Dasatinib 63 unstable angina pectoris 63 abacavir Ziagen 63 vitamin B# folic acid 63 argatroban 63 GOUT 63 antiviral efficacy 63 myelodysplastic myeloproliferative diseases 63 symptomatic BPH 63 plasma uric acid 63 mg simvastatin 63 plus dexamethasone 63 atazanavir sulfate 63 mRCC 63 BCG vaccinated 63 R adefovir dipivoxil 63 adalimumab 63 opioid dependent 63 EDARBI 63 emtricitabine tenofovir 63 budesonide foam 63 mg QD 63 HAART regimens 63 INCB# [001] 63 neutropenia dehydration dyspnea 63 paclitaxel eluting stents 63 MenACWY 63 leukemia AML 63 ergot derivatives 63 tenofovir FTC 63 receiving antiretroviral therapy 63 interferon alfa 2a 63 oxycodone CR 63 lopinavir 63 decitabine 63 resected pancreatic cancer 63 efavirenz EFV 63 mcg albinterferon alfa 2b 63 FOSRENOL ® 63 mg administered orally 63 CHOP chemotherapy 63 Ophena TM 63 Treatment Naive Patients 63 virologic suppression 63 CrCl 63 mcg dose 63 virologic responses 63 dose dose escalation 63 Peginterferon Alfa 2a 63 ® lenalidomide 63 idarubicin 63 virologically 63 pancreatic neuroendocrine tumors 63 mg ustekinumab 63 colorectal liver metastases 63 Platinol ® cisplatin 63 Tipranavir 63 Kinoid 63 etravirine 63 eszopiclone 63 relapsed AML 63 moderate renal impairment 63 MELD scores 63 Pegloticase 63 zolmitriptan 63 lopinavir r arm 63 mg TID 63 intravenous dosing 63 ALT elevations 63 lispro 63 HER2 expression 63 neurologic progression 63 Adalimumab 63 smoldering multiple myeloma 63 MGd 62 continuous intravenous infusion 62 MYLOTARG 62 receiving APTIVUS r 62 olanzapine quetiapine 62 herpes zoster shingles 62 overt nephropathy 62 imipenem 62 COPAXONE R 62 immunocompetent 62 guanfacine 62 aldosterone antagonists 62 lipid lowering therapy 62 adjunctive placebo 62 poor metabolizers 62 Pharmacokinetics PK 62 ABSSSI 62 palivizumab 62 tigecycline 62 Diamyd r 62 oxaliplatin Eloxatin 62 clinically evaluable 62 RAPTIVA 62 epoetin alpha 62 pegylated interferon alfa 2a 62 raltegravir 62 rFVIIa 62 Renal Impairment 62 teriflunomide 62 blinded randomized placebo controlled 62 Peg riba 62 Nebulized 62 dosing cohort 62 metastatic neuroendocrine tumors 62 baminercept 62 5mg dose 62 metformin sulfonylurea 62 Linagliptin 62 Free Survival PFS 62 Abrupt discontinuation 62 CALGB # [002] 62 VP# [004] 62 acarbose 62 EURIDIS 62 methotrexate therapy 62 Darunavir 62 tipranavir 62 hour bronchodilation 62 minimally symptomatic 62 Hypotension 62 median CD4 62 Gag polymorphisms 62 CIMZIA ™ 62 Atomoxetine 62 ALT flares 62 CYP#A# substrate 62 rtPA 62 olmesartan 62 headache abdominal pain 62 EFFEXOR XR 62 infliximab monotherapy 62 #mg dose [002] 62 Helicobacter pylori eradication 62 ddI 62 nucleotide analog 62 mg/m2 cohort 62 interferon therapy 62 inhaled tobramycin 62 levetiracetam 62 Femara letrozole 62 QTcF 62 mild hepatic impairment 62 SSRI SNRI 62 aminotransferases 62 alemtuzumab treated 62 3mg/kg 62 FOLFOX4 62 cisplatin gemcitabine 62 IFN alfa 62 buprenorphine implants 62 APTIVUS R 62 polytherapy 62 low dose Iluvien 62 Valcyte tablets 62 Thrombocytopenia 62 FOLFIRI alone 62 complete cytogenetic response 62 CYP#A# CYP#D# 62 basal bolus regimen 62 visilizumab 62 #mg q8h 62 recurrent glioma 62 palifermin 62 INTEGRILIN R 62 Pegasys ® 62 Telbivudine 62 aldosterone antagonist 62 Viread tenofovir disoproxil fumarate 62 peginterferon alpha 2a 62 headache nasopharyngitis 62 Doxil ® 62 dyslipidaemia 62 aripiprazole Abilify 62 Isentress raltegravir 62 Gleevec resistant 62 bosentan 62 piperacillin tazobactam 62 primary hypercholesterolemia 62 alicaforsen enema 62 systemic immunosuppressive 62 LEXIVA 62 ceftazidime 62 invasive candidiasis 62 non splenectomized 62 severe renal impairment 62 GH deficiency 62 ribavirin USP 62 HBV DNA 62 Sustiva efavirenz 62 Aflibercept 62 Relapsing Remitting Multiple Sclerosis 62 REVLIMID ® 62 plus prednisone 62 NRTI backbone 62 INSPIRE Trial Phase III 62 sustained virological response 62 ziconotide 62 DAPT 62 known sulfonamide allergy 62 diabetic neuropathic pain 62 painful diabetic neuropathy 62 Virologic 62 guanfacine extended release 62 preintervention 62 MIRAPEX 62 HBV infections 62 Paxil paroxetine 62 systemic corticosteroid 62 FOR FURTHER INFORMATION ABOUT 62 COPEGUS 62 nevirapine NVP 62 oxcarbazepine 62 Dose escalation 62 placebo controlled clinical trials 62 de novo AML 62 remifentanil 62 Subgroup analysis 62 CHAMPION PCI 62 saline placebo 62 bezafibrate 62 cardiovascular calcification 62 oral methylnaltrexone 62 chlorambucil 62 NRTI 62 inhaled budesonide 62 #mg/m# [002] 62 seropositive patients 62 annualized relapse 62 ug dose 62 adrenal suppression 62 CMV infection 62 ARB telmisartan 62 serum lipid levels 62 Pegylated Interferon 62 TNF antagonist 62 elevated serum creatinine 62 TAXOTERE ® 62 adefovir dipivoxil 62 Tasigna prolongs 62 ORENCIA ® 62 Peg IFN 62 postoperative AF 62 primidone 62 aromatase inhibitor therapy 62 viral suppression 62 esophageal candidiasis 62 co trimoxazole 62 TEAEs 62 antiangiogenic therapy 62 serum calcium levels 62 PASI scores 62 REYATAZ ritonavir 62 BYSTOLIC 62 PRADAXA 62 Demonstrates Positive 62 ziprasidone 62 plus COPEGUS 62 interferon alfa 62 bronchodilation 62 biochemical relapse 62 receptor tyrosine kinase inhibitor 62 Pegylated Liposomal Doxorubicin 62 CCR5 mAb 62 Vicriviroc 62 nalbuphine 62 anti Parkinsonian 62 PREZISTA r arm 62 hsCRP levels 62 cisplatin chemotherapy 62 placebo PBO 62 lopinavir ritonavir plus 62 DAS# CRP 62 Viral load 62 attain statistical significance 62 tinzaparin 62 HMG CoA reductase inhibitor 62 Mg Usa 62 ULORIC 62 events SAEs 62 benazepril 62 mitoxantrone 62 anti leukemic 62 prolonged QT interval 62 AZT 3TC 62 Protease inhibitor 62 MULTAQ 62 placebo dexamethasone 62 Sapacitabine 62 reactogenicity 62 rt PA 62 Certolizumab pegol 62 -#.# log# copies mL 62 psoriatic arthritis PsA 62 mg BID 62 zidovudine lamivudine 62 undergoing peritoneal dialysis 62 comparator arm 62 hematological parameters 62 visceral metastases 62 symptom exacerbation 61 5mg/kg 61 citalopram hydrobromide 61 hA# 61 sotalol 61 immune thrombocytopenic purpura ITP 61 peg IFN 61 Telithromycin 61 TransVax ™ 61 YONDELIS 61 nutlin 3a 61 corticosteroid therapy 61 Zavesca ® 61 refractory CTCL 61 MCyR 61 steroid dexamethasone 61 postexposure prophylaxis 61 Atypical Hemolytic Uremic Syndrome 61 eculizumab therapy 61 pouchitis 61 heavily pretreated patients 61 receiving golimumab 61 relapsed myeloma 61 Tarceva TM 61 leukemia ALL 61 severe exacerbations 61 quetiapine XR 61 novel VDA molecule 61 hematologic toxicity 61 humanized interleukin 6 61 active comparator 61 TYSABRI therapy 61 acromegalic patients 61 autoantibody positive 61 recurrent atrial fibrillation 61 HBeAg 61 hypereosinophilic syndrome 61 liver histology 61 Pegylated interferon 61 double blinded randomized 61 Adjunctive 61 AIR CF1 61 acute gout flares 61 antiarrhythmic drug 61 epoetin beta 61 ORENCIA R 61 asymptomatic metastatic 61 CCR5 tropic 61 tarenflurbil 61 Oral Fingolimod 61 serum urate 61 rizatriptan 61 pegylated interferon alfa 2b 61 Index CDAI 61 immunomodulatory therapy 61 cardiac repolarization 61 bronchoalveolar lavage fluid 61 lamivudine resistant 61 golimumab CNTO 61 oral antidiabetic medication 61 receiving CIMZIA #mg 61 fluoxetine paroxetine 61 anemia hemoglobin 61 refractory AML 61 gemifloxacin 61 #.#mg/dL 61 oral antidiabetes 61 Pharmacokinetic 61 Folfox 61 EDEMA3 trial 61 MAS XR 61 bendamustine 61 oral prednisolone 61 elevated LDL cholesterol 61 lamotrigine 61 DLTs 61 hypophosphatemia 61 IOP lowering 61 Refractory Hodgkin Lymphoma 61 morphometric vertebral fractures 61 tumor histology 61 pimozide 61 Pemetrexed 61 splenectomized patients 61 VIRAMUNE R 61 fistulizing Crohn disease 61 SIV infection 61 chronic HCV 61 naive HCV 61 GSK# [001] 61 Febrile neutropenia 61 COMBIVIR 61 FluCAM 61 Cethromycin 61 COPEGUS R 61 umol L 61 chronic HCV genotype 61 Patients Treated With 61 buprenorphine naloxone 61 stage IIIB 61 intravenous cyclophosphamide 61 peginterferon alfa 2a 61 administered concomitantly 61 parkinsonian symptoms 61 intra articular injection 61 neuroleptic 61 ibandronate 61 paroxetine sertraline 61 PEG IFN 61 Hypertensive adverse reactions 61 HCD# [002] 61 Coadministration 61 mycophenolate mofetil 61 Triapine R 61 caspofungin 61 Non inferiority 61 #mg BID [003] 61 Decompensated Heart Failure 61 pegIFN 61 risperidone Risperdal 61 cytarabine daunorubicin 61 anticholinergic agents 61 fluticasone salmeterol 61 mg/m2 administered 61 Patients Receiving 61 undetectable HCV RNA 61 intravenous bisphosphonates 61 phase Ib 61 TYGACIL 61 metastatic malignant 61 RECORD1 61 IV bolus 61 Aggrastat ® tirofiban hydrochloride 61 dacarbazine DTIC 61 tamsulosin 61 controlled dose escalation 61 undetectable viral load 61 virologic 61 pooled comparator 61 lymphocyte counts 61 receiving SIMPONI 61 DEB# 61 vWF 61 samalizumab 61 COPD exacerbations 61 Gilead Viread 61 Plicera 61 mapatumumab 61 6MWD 61 Alequel 61 dexamethasone Decadron 61 Val HeFT 61 Golimumab 61 CTAP# Capsules 61 Blinatumomab 61 COPEGUS ribavirin 61 COU AA 61 gliclazide 61 Proellex TM 61 refractory gout 61 lipid lowering agents 61 lumbar spine BMD 61 lipid lowering therapies 61 citalopram Celexa 61 recurrent malignant glioma 61 anakinra 61 inhaled corticosteroid therapy 61 Kaplan Meier estimate 61 Dementia Related Psychosis 61 HBV DNA levels 61 SGPT 61 histologically confirmed 61 interferon gamma 1b 61 indinavir Crixivan 61 prucalopride 61 stavudine 61 Albuferon TM 61 hepatic insufficiency 61 CR# vcMMAE 61 FOLFOX6 61 relapsed CLL 61 paroxysmal AF 61 INFERGEN 61 cEVR 61 transaminase elevations 61 tapentadol ER 61 PEGINTRON TM 61 neutrophil counts 61 HCV antibody 61 viremia 61 liver transplant recipients 61 hypofractionated radiation 61 glycosylated hemoglobin HbA1c 61 TRAIL induced apoptosis 61 pamidronate 61 Monotherapy 61 zoledronate 61 antithymocyte globulin 61 seropositivity 61 Apidra ® 61 Complicated Skin 61 myopathy rhabdomyolysis 61 Lamotrigine 61 R lenalidomide 61 urate lowering therapy 61 hemagglutination inhibition 61 EOquin TM phase 61 ATACAND 61 CK # administered 61 CMV infections 61 boosted protease inhibitor 61 NNRTI 61 vWD 61 sUA 61 Enzastaurin 61 papillary renal cell carcinoma 61 rindopepimut 61 placebo controlled dose escalation 61 oral levofloxacin 61 postprocedure 61 Omacetaxine 61 mutated KRAS 61 sorafenib tablets 61 mcg kg 61 PsA 61 HGS ETR2 61 Ribavirin causes 61 HCV replicon 61 VIIBRYD 61 Elitek 61 biologic DMARDs 61 underwent percutaneous coronary 61 irbesartan 61 basiliximab 61 relapsed refractory multiple myeloma 61 CLINICAL STUDIES 61 Tolvaptan 61 Atripla combines 61 tegaserod 61 docetaxel chemotherapy 61 hours postdose 61 non constipating irritable 61 mepolizumab 61 potentially hepatotoxic 61 prospectively defined 61 macrolide antibiotic 61 EDSS scores 61 nondiabetic patients 61 FDA defined valvulopathy 61 patientswith 61 microbiologically evaluable 61 INVANZ 61 acute mania 61 dasatinib Sprycel ® 61 FASLODEX 61 Castration Resistant Prostate Cancer 61 receiving PREZISTA r 61 ER CHOP 61 chronic HBV infection 61 busulfan 61 adefovir treated 61 unresectable HCC 61 Hematologic 61 adjunctive ABILIFY 61 icatibant 61 euthyroid 61 nitrofurantoin 61 Fingolimod 61 EPIVIR 61 amprenavir 61 unfractionated heparin UFH 61 calcineurin inhibitor 61 QD dosing 61 renal toxicity 61 squamous histology 61 asthma exacerbation 61 Budesonide foam crofelemer 61 PEG SN# 60 liver transaminases 60 FluCAM arm 60 BR.# 60 darunavir 60 genotype 1a 60 intravenous CK # 60 subcutaneous PRO 60 HBeAg negative chronic hepatitis 60 rhGH 60 PRTX 60 pharmacodynamic PD 60 Bezielle 60 TAXOTERE R 60 d4T 60 randomized multicenter trial 60 concurrent ITP 60 TNF antagonist therapy 60 demonstrated clinically meaningful 60 metastatic renal cell carcinoma 60 rapid virologic response 60 prednisone prednisolone 60 NNRTIs 60 induce orthostatic hypotension 60 sJIA 60 ACZ# 60 antimuscarinic 60 quetiapine fumarate 60 pharmacodynamic parameters 60 chronic eosinophilic leukemia 60 Infected Patients 60 budesonide inhalation suspension 60 antidepressants fluoxetine 60 PD LID 60 paroxetine Paxil 60 SNT-MC#/idebenone 60 decompensated cirrhosis 60 candesartan cilexetil 60 Pafuramidine 60 nucleoside analogues 60 efavirenz Sustiva 60 AST ALT 60 IMiDs ® 60 transcriptase inhibitor NNRTI 60 haloperidol Haldol 60 nab paclitaxel